Gorodenkoff - stock.adobe.com
Other Clinical Studies where HI-MAG scientists are involved:
- MSOT ENDO – Prospective evaluation of multispectral optoacoustic tomography (MSOT) for hemodynamic assessment in patients with peripheral arterial disease undergoing peripheral endovascular interventions
- Dose-ranging study to evaluate the efficacy, safety, and tolerability of AMG 133 in adult participants with overweight or obesity, with or without Type 2 Diabetes mellitus
- A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of Maridebart Cafraglutide in adult participants without Type 2 Diabetes mellitus who have obesity or are overweight
- A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of Maridebart Cafraglutide in adult participants with Type 2 Diabetes mellitus who have obesity or are overweight
- A study to test whether different doses of BI 456906 are effective in treating adults with Type 2 Diabetes
- A study in people with obesity to test the effects of different doses of BI 456906 compared with Semaglutide on glucagon receptor activity in the liver
- A study of Tirzepatide (LY3298176) compared with dulaglutide on major cardiovascular events in participants With Type 2 Diabetes
- A research study to see how well CagriSema helps people with excess body weight lose weight
- Semaglutide wffects on heart disease and stroke in patients with overweight or obesity
- SURMOUNT-ADOLESCENTS-2: Efficacy and safety of Tirzepatide once weekly versus placebo for the treatment of obesity and weight-related comorbidities in adolescents (12-17yrs): A randomized, double-blind, placebo-controlled study
- Head-to-head comparison of SIROlimus versus Paclitaxel drug-eluting balloon angioplasty in the femoropopliteal artery
- Prospective multi-center randomized controlled trial to evaluate the safety and efficacy of SiroLIMus drug coated balloon versus non-coated standard angioplasty for the treatment of infrapopliteal occlusions in patients with peripheral arterial disease
- Prospective, randomized, multi-center study for the treatment of subjects with symptomatic femoropopliteal artery disease with the Ranger™ Paclitaxel Coated PTA Balloon Catheter (study arm) vs. the IN.PACT™ Drug Eluting Balloon (control arm)
- Multicenter randomized controlled trial to assess the effectiveness of Paclitaxel-coated Luminor® Balloon Catheter vs. uncoated balloon catheter in the superficial femoral and popliteal arteries to prevent vessel restenosis or reocclusion
- STEPYoung: A research study on how well semaglutide helps children and teenagers with excess body weight lose weight
- STEPTeens: Weight maintenance in adolescents with obesity. Long-term treatment with Semaglutide s.c. 2.4 mg once-weekly.
- EMENATE: Setmelanotide phase 3 treatment trial in patients with rare genetic disorders of obesity
- MSOT ENDO – Prospective evaluation of multispectral optoacoustic tomography (MSOT) for hemodynamic assessment in patients with peripheral arterial disease undergoing peripheral endovascular interventions
- Dose-ranging study to evaluate the efficacy, safety, and tolerability of AMG 133 in adult participants with overweight or obesity, with or without Type 2 Diabetes mellitus
- A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of Maridebart Cafraglutide in adult participants without Type 2 Diabetes mellitus who have obesity or are overweight
- A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of Maridebart Cafraglutide in adult participants with Type 2 Diabetes mellitus who have obesity or are overweight
- A study to test whether different doses of BI 456906 are effective in treating adults with Type 2 Diabetes
- A study in people with obesity to test the effects of different doses of BI 456906 compared with Semaglutide on glucagon receptor activity in the liver
- A study of Tirzepatide (LY3298176) compared with dulaglutide on major cardiovascular events in participants With Type 2 Diabetes
- A research study to see how well CagriSema helps people with excess body weight lose weight
- Semaglutide wffects on heart disease and stroke in patients with overweight or obesity
- SURMOUNT-ADOLESCENTS-2: Efficacy and safety of Tirzepatide once weekly versus placebo for the treatment of obesity and weight-related comorbidities in adolescents (12-17yrs): A randomized, double-blind, placebo-controlled study
- Head-to-head comparison of SIROlimus versus Paclitaxel drug-eluting balloon angioplasty in the femoropopliteal artery
- Prospective multi-center randomized controlled trial to evaluate the safety and efficacy of SiroLIMus drug coated balloon versus non-coated standard angioplasty for the treatment of infrapopliteal occlusions in patients with peripheral arterial disease
- Prospective, randomized, multi-center study for the treatment of subjects with symptomatic femoropopliteal artery disease with the Ranger™ Paclitaxel Coated PTA Balloon Catheter (study arm) vs. the IN.PACT™ Drug Eluting Balloon (control arm)
- Multicenter randomized controlled trial to assess the effectiveness of Paclitaxel-coated Luminor® Balloon Catheter vs. uncoated balloon catheter in the superficial femoral and popliteal arteries to prevent vessel restenosis or reocclusion
- STEPYoung: A research study on how well semaglutide helps children and teenagers with excess body weight lose weight
- STEPTeens: Weight maintenance in adolescents with obesity. Long-term treatment with Semaglutide s.c. 2.4 mg once-weekly.
- EMENATE: Setmelanotide phase 3 treatment trial in patients with rare genetic disorders of obesity